Reset filter
Mots-clés
Pulmonaal gezwel ×
Afficher plus Mots-clés
Table des matières
  1. 1. Essai clinique
  2. 2. Routinedokumentation
  3. 3. Études de registres/cohortes
  4. 4. Assurance qualité
  5. 5. Standard de données
  6. 6. Questionnaire pour les patients
  7. 7. Spécialité médicale
Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

329 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

dbGaP phs001075 Sequencing to Guide Cancer Care (CanSeq) - pht006108.v1.p1

- 23/06/2023 - 4 Formulaires, 1 Groupe Item, 3 Eléments de données, 1 Langue
Groupe Item: pht006108
Principal Investigator: Levi Garraway, Dana Farber Cancer Institute, Boston, MA, USA MeSH: Neoplasms,Colonic Neoplasms,Lung Neoplasms,Adenocarcinoma of lung https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001075 The overall goal of the CanSeq U01 project is to study the impact of whole-exome sequencing (WES) on the clinical care of cancer patients and oncology provider practices. The aims of Project 1 are to implement and establish the feasibility of germline and somatic WES in patients with advanced solid tumors (lung and colon); to develop a framework for interpreting and reporting for exome sequencing data; to determine the proportion of patients with "actionable items" compared to existing technologies; and to report on the percentage of patients in whom unique WES findings led to a clinical action. The aims of Project 2 are to implement a production-scale platform for WES from archival (FFPE) material; to identify biologically relevant somatic and germline alterations existing in tumor/normal DNA from individual patients; to produce an evidence-based list of clinically "actionable" genetic alterations; and to develop inferential models that predict the utility of tumor genomic data within the larger clinical context. The goals of Project 3 are to describe the impact of information derived through WES on cancer patients; to test the hypothesis that patients will want to receive information about all potentially informative somatic and germline variants; to study patients' understanding of disclosed genomic information; and to describe the experiences of oncology providers as they implement WES into cancer care delivery.

pht006109.v1.p1

1 Groupe Item 3 Eléments de données

pht006111.v1.p1

1 Groupe Item 3 Eléments de données

pht006110.v1.p1

1 Groupe Item 2 Eléments de données

Radiation Therapy Oncology Group Phase III Lung Prophylactic Cranial RT Neurocognitive Evaluation Summary Form NCT00048997

- 03/06/2015 - 1 Formulaire, 3 Groupes Item, 18 Eléments de données, 1 Langue
Groupes Item: Header Module, Neurocognitive Evaluation, CCRR MODULE
Radiation Therapy Oncology Group Phase III Lung Prophylactic Cranial RT Neurocognitive Evaluation Summary Form NCT00048997 Radiation Therapy in Preventing CNS Metastases in Patients With Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A5472EED-0175-07F2-E034-080020C9C0E0

Radiation Therapy Oncology Group Phase III Lung Prophylactic Cranial RT MMSE NCT00048997

- 03/06/2015 - 1 Formulaire, 3 Groupes Item, 35 Eléments de données, 1 Langue
Groupes Item: Header Module, Neurocognitive Evaluation, CCRR MODULE
Radiation Therapy Oncology Group Phase III Lung Prophylactic Cranial RT MMSE NCT00048997 Radiation Therapy in Preventing CNS Metastases in Patients With Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A5D1AB4A-E01B-3595-E034-080020C9C0E0

Prestudy form NSCLC Stage III NCT00020709

- 20/09/2021 - 1 Formulaire, 4 Groupes Item, 25 Eléments de données, 1 Langue
Groupes Item: SWOG clinical trial administrative data, PATIENT AND DISEASE DESCRIPTION, CURRENT LABORATORY VALUES (SI UNITS), Notes
NCT00020709 S0023: Combination Chemo Plus RT With or Without Gefitinib in Treating Patients With Unresectable Stage III NSCLC Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9CA62D43-4AA8-361C-E034-080020C9C0E0

Treatment Summary NSCLC Stage III RTOG NCT00533949

- 20/09/2021 - 1 Formulaire, 3 Groupes Item, 36 Eléments de données, 1 Langue
Groupes Item: RTOG clinical trial administrative data, Assessment of Chemotherapy, REPORT ALL CONTINUING OR NEW ADVERSE EVENTS
NCT00533949 TF: Radiation Therapy Oncology Group Phase III High-dose Vs Standard-dose Conformal XRT with Chemotherapy Treatment Summary Form High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=24FB4F78-9A8F-669C-E044-0003BA3F9857

CALGB: Thoracic Lymph Node Sampling Report NCT00499330

- 20/09/2021 - 1 Formulaire, 7 Groupes Item, 24 Eléments de données, 1 Langue
Groupes Item: Header, Patient demographics, Surgical Approach Right Sided Nodes, Right Sided Nodes, Surgical Approach Left Sided Nodes, Left Sided Nodes, Footer module
CALGB: Thoracic Lymph Node Sampling Report NCT00499330 Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=225E819D-890F-6685-E044-0003BA3F9857

Lung Cancer NCT00738881 On-Study - North Central Cancer Treatment Group N0723 On-Study Form - 2731649v1.0 - North Central Cancer Treatment Group N0723 On-Study Form

- 20/09/2021 - 1 Formulaire, 8 Groupes Item, 35 Eléments de données, 1 Langue
Groupes Item: Header Module, Description of Primary Disease, Chronology of Diagnoses, Metastatic Site(s), Previous Surgery Related To The Tumor, Prior Radiation Therapy, Prior systemic therapy, Descriptive Factors
North Central Cancer Treatment Group N0723 On-Study Form Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=46FF63E8-1055-1831-E044-0003BA3F9857

CALGB 140503 PRE-REGISTRATION WORKSHEET

- 20/09/2021 - 1 Formulaire, 3 Groupes Item, 20 Eléments de données, 1 Langue
Groupes Item: Protocol Administration, Patient Demographics/Pre-Treatment Characteristics, Notes:
CALGB 140503 PRE-REGISTRATION WORKSHEET Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6E4AB7DA-A34F-776C-E040-BB89AD430B3B

Registration Worksheet NSCLC Z4032 NCT00107172

- 20/09/2021 - 1 Formulaire, 8 Groupes Item, 55 Eléments de données, 1 Langue
Groupes Item: Header Module, Patient demographics, Pre-Operative Criteria, CT Scan of Chest/Upper Abdomen, Pregnancy Test, Clinical Stage, Pre-operative PFT's, Footer Module
Z4032 Registration Worksheet NCT00107172 Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F20F53D3-C88B-6847-E034-0003BA3F9857

Intra-operative Registration/Randomization Lung Cancer CALGB 140503 NCT00499330

- 20/09/2021 - 1 Formulaire, 8 Groupes Item, 26 Eléments de données, 1 Langue
Groupes Item: Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Patient Demographics/Pre-Treatment Characteristics2, Patient Demographics/Pre-Treatment Characteristics3, Certification Of Eligibility, Protocol Design, Companion Studies, Notes:
Lung Cancer NCT00499330 Registration - CALGB 140503 INTRA-OPERATIVE REGISTRATION/RANDOMIZATION WORKSHEET - 2916823v1.0 CALGB 140503 INTRA-OPERATIVE REGISTRATION/RANDOMIZATION WORKSHEET Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6E4AB7DA-A794-776C-E040-BB89AD430B3B

Treatment and Response Form Lung Cancer (CALGB 30607)

- 20/09/2021 - 1 Formulaire, 4 Groupes Item, 32 Eléments de données, 1 Langue
Groupes Item: Header Section, Survival Status, Treatment, Response
CALGB: 30607 Treatment and Response Form Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy NCT00693992 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=35681A7B-54DB-54F0-E044-0003BA3F9857

Lung Cancer NCT00045162 Pre-Study - SOUTHWEST ONCOLOGY GROUP EXTENSIVE SMALL CELL LUNG CARCINOMA PRESTUDY FORM - 2402234v1.0 - SOUTHWEST ONCOLOGY GROUP EXTENSIVE SMALL CELL LUNG CARCINOMA PRESTUDY FORM

- 20/09/2021 - 1 Formulaire, 5 Groupes Item, 19 Eléments de données, 1 Langue
Groupes Item: Header, Patient and Disease Description, Current Laboratory Values, Prior Treatment Related To This Cancer, Comments
SOUTHWEST ONCOLOGY GROUP EXTENSIVE SMALL CELL LUNG CARCINOMA PRESTUDY FORM S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=001A8323-2611-48BE-E044-0003BA3F9857

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial